Hence, up-regulation of IL1R2 expression in MDSC monocytes of COVID19-ACEi patients may play a key role in attenuating hyperinflammatory responses triggered by CD14 + IL1β monocytes [42]. The gene discussed is CD14; the disease is COVID-19.